Ketamine-Assisted Couple Therapy CE Course
Ketamine-assisted couple therapy (couples' KAP) is a novel method for helping to heal relationship distress. Dr. Kayla Knopp and Dr. Chandra Khalifian will describe a model of couples' KAP that combines principles of evidence-based couple therapy with the latest research on psychedelic-assisted therapies. This workshop will describe the neuroscience of ketamine therapy, the rationale for using ketamine to support change in couple therapy, and the research to date. Attendees will also learn the foundations of couples' KAP in clinical practice, including assessment and case formulation, preparation, dyadic dosing, and couples' integration.
Learning Objectives:
Identify three key mechanisms of ketamine and how they may support change in couple therapy.
Describe the current state of the research on ketamine-assisted couple therapy.
Explain the principles of assessment, preparation, dosing, and integration in couples' KAP.
This session is designed for group practice owners and therapists who want a clear, real-world perspective on adding KAP to their services.
Dr. Kayla Knopp
Ph.D., Licensed Clinical Psychologist (CA PSY 32016)
Kayla (she/her) is a clinical psychologist, researcher, and educator who works with people building expansive, empowering, and creative intimate relationships. She is certified in Integrative Behavioral Couple Therapy and has worked extensively with trauma, mental health diagnoses, and emotion regulation in both community and hospital settings. She co-founded Enamory to help individuals and relationships thrive, and is one of only a handful of clinicians worldwide specializing in psychedelic-assisted couple therapy. She earned her Ph.D. at the University of Denver and completed her internship and postdoctoral fellowship at the VA San Diego / UCSD consortium.
Dr. Chandra Khalifian
Ph.D., Licensed Clinical Psychologist (CA PSY 31914)
Chandra is a clinical psychologist, researcher, and educator focused on couple-based treatments for relationship distress and mental health, including evidence-based therapies enhanced with psychedelics. She is one of very few clinicians in the world specializing in psychedelic-assisted couple therapy and presents her work at conferences internationally. She trained at UC Berkeley, completed her Ph.D. at the University of Maryland, Baltimore County, and her internship and postdoctoral fellowship at the UC San Diego / VA Consortium.
Accreditation Statements
Journey Clinical is approved by the American Psychological Association to sponsor continuing education for psychologists. Journey Clinical maintains responsibility for this program and its content.
Journey Clinical (Provider #2246) is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on course acceptance. ACE provider approval period: August 21, 2026 – March 31, 2029. Social workers completing this course receive 1 asynchronous distance learning continuing education credits.
Journey Clinical has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7667. Programs that do not qualify for NBCC credit are clearly identified. Journey Clinical is solely responsible for all aspects of its programs.
No commercial support was provided for this course. There are no known conflicts of interest.
If you have any questions, or should you require any special accommodations to benefit from this content, please do not hesitate to reach out to cecredits@journey.clinic with your request. We will do our best to accommodate your needs within a reasonable time frame of 1 week.